{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T02:25:18Z","timestamp":1785551118980,"version":"3.56.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["001357"],"award-info":[{"award-number":["001357"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015502","name":"Dialysis Clinics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015502","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.amjms.2021.03.009","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T02:51:12Z","timestamp":1617072672000},"page":"24-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study"],"prefix":"10.1016","volume":"362","author":[{"given":"Mark J.","family":"Schwade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillie","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Waller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Baer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufei","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufaddal F.","family":"Kheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy B.","family":"Bollag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0001","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2013.11.013","article-title":"Psoriasis prevalence among adults in the United States","volume":"70","author":"Rachakonda","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0002","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0003","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/09546630701364768","article-title":"Psoriasis comorbidities","volume":"19","author":"Gottlieb","year":"2008","journal-title":"J Dermatol Treat"},{"issue":"10","key":"10.1016\/j.amjms.2021.03.009_bib0004","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2013.5015","article-title":"Psoriasis severity and the prevalence of major medical comorbidity: a population-based study","volume":"149","author":"Yeung","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0005","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","article-title":"Psoriasis and comorbid diseases: Epidemiology","volume":"76","author":"Takeshita","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0006","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus: A systematic review and meta-analysis","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0007","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2133.2010.09941.x","article-title":"Cause-specific mortality in patients with severe psoriasis: A population-based cohort study in the UK","volume":"163","author":"Abuabara","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.amjms.2021.03.009_bib0008","doi-asserted-by":"crossref","first-page":"f5961","DOI":"10.1136\/bmj.f5961","article-title":"Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study","volume":"347","author":"Wan","year":"2013","journal-title":"Bmj"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0009","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jdermsci.2015.03.012","article-title":"Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study","volume":"78","author":"Chi","year":"2015","journal-title":"J Dermatol Sci"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/bjd.13599","article-title":"Increased risk of glomerulonephritis and chronic kidney disease in relation to the severity of psoriasis, concomitant medication, and comorbidity: a nationwide population-based cohort study","volume":"173","author":"Chiu","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0011","first-page":"1","article-title":"Risk of end-Stage Renal Disease in psoriatic patients: Real-World Data from a nationwide population-Based cohort Study","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0012","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000247420","article-title":"Relation between urinary albumin excretion and skin involvement in patients with psoriasis","volume":"185","author":"Cecchi","year":"1992","journal-title":"Dermatology"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0013","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1159\/000184916","article-title":"High prevalence of microproteinuria, an early index of renal impairment, in patients with diffuse psoriasis","volume":"48","author":"Madeddu","year":"1988","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0014","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11255-011-9966-1","article-title":"The spectrum of renal abnormalities in patients with psoriasis","volume":"44","author":"Dervisoglu","year":"2012","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0015","first-page":"438","article-title":"Chronic kidney disease in psoriasis: A cohort study","volume":"18","author":"Conti","year":"2020","journal-title":"J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG"},{"issue":"suppl 2","key":"10.1016\/j.amjms.2021.03.009_bib0016","doi-asserted-by":"crossref","first-page":"ii83","DOI":"10.1136\/ard.2004.030791","article-title":"Psoriasis treatment: traditional therapy","volume":"64","author":"Lebwohl","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"suppl 2","key":"10.1016\/j.amjms.2021.03.009_bib0017","doi-asserted-by":"crossref","first-page":"ii87","DOI":"10.1136\/ard.2004.032276","article-title":"Psoriasis treatment: Current and emerging directed therapies","volume":"64","author":"Winterfield","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0018","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaad.2005.03.050","article-title":"Decision points for the initiation of systemic treatment for psoriasis","volume":"53","author":"Feldman","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0019","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2217\/14750708.1.2.319","article-title":"Therapy treatment options for psoriasis: topical and systemic","volume":"1","author":"Mikhail","year":"2004","journal-title":"Therapy"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s13555-016-0153-2","article-title":"Under-treatment of patients with moderate to severe psoriasis in the United States: Analysis of medication usage with health plan data","volume":"7","author":"Armstrong","year":"2017","journal-title":"Dermatol Ther"},{"issue":"9811","key":"10.1016\/j.amjms.2021.03.009_bib0021","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"Levey","year":"2012","journal-title":"The lancet"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0022","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1159\/000168012","article-title":"Infection of hemodialysis catheters: Incidence and mechanisms","volume":"9","author":"Almirall","year":"1989","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0023","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1053\/ajkd.2002.31405","article-title":"Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI clinical practice guidelines for vascular access","volume":"39","author":"Stevenson","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0024","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11934-014-0471-9","article-title":"Chronic kidney disease and premature ageing of the adaptive immune response","volume":"16","author":"Betjes","year":"2015","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0025","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1053\/j.ackd.2019.01.004","article-title":"Immune Dysfunction and Risk of Infection in Chronic Kidney Disease","volume":"26","author":"Syed-Ahmed","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"issue":"176","key":"10.1016\/j.amjms.2021.03.009_bib0026","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00003086-198306000-00016","article-title":"Charnley low-friction arthroplasty in patients with psoriasis","author":"Menon","year":"1983","journal-title":"Clin Orthop"},{"issue":"248","key":"10.1016\/j.amjms.2021.03.009_bib0027","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/00003086-198911000-00018","article-title":"Total knee arthroplasty in patients with psoriasis","author":"Stern","year":"1989","journal-title":"Clin Orthop"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0028","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000249365","article-title":"Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes","volume":"172","author":"Lindeg\u00e5rd","year":"1986","journal-title":"Dermatology"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0029","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1023\/A:1007302330323","article-title":"Psoriasis is a risk factor for hip-prosthesis infection","volume":"13","author":"Drancourt","year":"1997","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0030","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.jaad.2010.08.036","article-title":"Increased risk of infectious disease requiring hospitalization among patients with psoriasis: A population-based cohort","volume":"65","author":"Wakkee","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.amjms.2021.03.009_bib0031","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116077","article-title":"Psoriasis and the risk of pneumonia: a population-based study","volume":"9","author":"Kao","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0033","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0034","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0035","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/j.ajkd.2011.10.049","article-title":"Risk of herpes zoster in patients treated with long-term hemodialysis: a matched cohort study","volume":"59","author":"Kuo","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1016\/j.amjms.2021.03.009_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179447","article-title":"Increased risk of herpes zoster in patients with psoriasis: A population-based retrospective cohort study","volume":"12","author":"Tsai","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.amjms.2021.03.009_bib0037","unstructured":"Klein A, Johnston D. Pericarditis and Pericardial Conditions. Published online August 14, 2015. https:\/\/my.clevelandclinic.org\/departments\/heart\/patient-education\/webchats\/pericardial-conditions\/2765_understanding-pericarditis-inflammation-of-the-heart-sac"},{"key":"10.1016\/j.amjms.2021.03.009_bib0038","first-page":"2013","article-title":"A rare side effect due to TNF-alpha blocking agent: acute pleuropericarditis with adalimumab","author":"Ozkan","year":"2013","journal-title":"Case Rep Rheumatol"},{"issue":"2","key":"10.1016\/j.amjms.2021.03.009_bib0039","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-\u03b1 inhibitors in patients with rheumatologic conditions","volume":"143","author":"de Gannes","year":"2007","journal-title":"Arch Dermatol"},{"issue":"4","key":"10.1016\/j.amjms.2021.03.009_bib0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10754-007-9019-6","article-title":"The organization and financing of kidney dialysis and transplant care in the United States of America","volume":"7","author":"Hirth","year":"2007","journal-title":"Int J Health Care Finance Econ"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0041","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1540-9740.2005.03716.x","article-title":"Smoking and psoriasis","volume":"4","author":"Behnam","year":"2005","journal-title":"Skinmed"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0042","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1365-2133.2011.10526.x","article-title":"Smoking and pathogenesis of psoriasis: a review of oxidative, inflammatory and genetic mechanisms","volume":"165","author":"Armstrong","year":"2011","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.amjms.2021.03.009_bib0043","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ced.12013","article-title":"Alcohol and psoriasis: Sobering thoughts","volume":"38","author":"Adamzik","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0044","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaad.2004.07.045","article-title":"The prevalence of psoriasis in African Americans: results from a population-based study","volume":"52","author":"Gelfand","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"10.1016\/j.amjms.2021.03.009_bib0045","first-page":"16","article-title":"Psoriasis in skin of color: epidemiology, genetics, clinical presentation, and treatment nuances","volume":"7","author":"Alexis","year":"2014","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"9","key":"10.1016\/j.amjms.2021.03.009_bib0046","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tig.2010.06.006","article-title":"Psoriasis genetics: breaking the barrier","volume":"26","author":"Roberson","year":"2010","journal-title":"Trends Genet"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0047","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.jaad.2010.10.032","article-title":"Ocular psoriasis","volume":"65","author":"Rehal","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0048","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-4632.2011.05424.x","article-title":"Ocular findings in patients with psoriasis","volume":"52","author":"Kilic","year":"2013","journal-title":"Int J Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0049","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jdv.12239","article-title":"The prevalence of onychomycosis in psoriatic patients: A systematic review","volume":"28","author":"Klaassen","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"10.1016\/j.amjms.2021.03.009_bib0050","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jamadermatol.2013.5264","article-title":"Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: Findings from the National Psoriasis Foundation surveys, 2003-2011","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0051","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jaad.2007.06.042","article-title":"Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey","volume":"57","author":"Horn","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2021.03.009_bib0052","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jaad.2007.08.046","article-title":"Herpes zoster: Epidemiology, natural history, and common complications","volume":"57","author":"Weinberg","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0053","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1093\/infdis\/153.5.840","article-title":"Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients","volume":"153","author":"Ljungman","year":"1986","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.amjms.2021.03.009_bib0054","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/jdv.12307","article-title":"The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions","volume":"28","author":"Adelzadeh","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.amjms.2021.03.009_bib0055","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1001\/jamadermatol.2014.4956","article-title":"Systemic therapy for psoriasis and the risk of herpes zoster: A 500 000 person-year study","volume":"151","author":"Shalom","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0056","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2013-205148","article-title":"Psoriatic arthritis treatment and the risk of herpes zoster","volume":"75","author":"Zisman","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.amjms.2021.03.009_bib0057","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/j.1468-3083.2011.04230.x","article-title":"Risk of Herpes zoster in patients with psoriasis treated with biologic drugs","volume":"26","author":"Dreiher","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"9","key":"10.1016\/j.amjms.2021.03.009_bib0058","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2013.1099","article-title":"Association between the initiation of Anti\u2013Tumor necrosis factor therapy and the risk of herpes zoster","volume":"309","author":"Winthrop","year":"2013","journal-title":"Jama"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0059","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/ckj\/sfy058","article-title":"Mortality risk after herpes zoster infection in end-stage renal disease patients","volume":"12","author":"Ahn","year":"2018","journal-title":"Clin Kidney J"},{"issue":"4","key":"10.1016\/j.amjms.2021.03.009_bib0060","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/cid\/civ930","article-title":"Effectiveness of herpes zoster vaccine in patients 60 years and older with end-stage renal disease","volume":"62","author":"Tseng","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.amjms.2021.03.009_bib0061","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jaad.2019.03.017","article-title":"A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation","volume":"81","author":"Baumrin","year":"2019","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.amjms.2021.03.009_bib0062","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1093\/cid\/cit684","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host","volume":"58","author":"Rubin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.amjms.2021.03.009_bib0063","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1475-6773.2007.00822.x","article-title":"Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database","volume":"43","author":"Quan","year":"2008","journal-title":"Health Serv Res"},{"issue":"8","key":"10.1016\/j.amjms.2021.03.009_bib0064","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pds.3447","article-title":"Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996\u20132009","volume":"22","author":"Asgari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.amjms.2021.03.009_bib0065","series-title":"CMS 2728: What Good Is It?","author":"Eggers","year":"2010"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T11:15:38Z","timestamp":1762082138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0002962921001002"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.03.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of psoriasis in end-stage renal disease patients is associated with decreased mortality: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.03.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}